Stay updated on 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.

Latest updates to the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedRevision updated from v3.3.1 to v3.3.2 on the page; no changes to study content or navigation are evident—To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check13 days agoChange DetectedAdded a site revision note: Revision: v3.3.1. Removed the 'Multiple myeloma' topic and related topic 'MedlinePlus Genetics,' along with the prior revision note 'Revision: v3.2.0'.SummaryDifference0.2%

- Check20 days agoChange DetectedThe funding lapse notice was removed from the page, and no other study content was changed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.4%

- Check27 days agoChange DetectedAdded related topics: Multiple myeloma and MedlinePlus Genetics to the page's Related Topics section to provide background resources. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check34 days agoChange DetectedThe new screenshot shows minor layout and styling adjustments. There are no changes to the study's title, criteria, endpoints, or results.SummaryDifference0.4%

- Check42 days agoChange DetectedDifference0.2%

Stay in the know with updates to 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the 89Zr-DFO-daratumumab Imaging in Multiple Myeloma Clinical Trial page.